Stay updated on Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial
Sign up to get notified when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.

Latest updates to the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision v3.7.0 was added and v3.6.6 was removed. This reflects an update to the record's version history rather than changes to the study data.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedThe history page shows a new revision tag v3.6.6 replacing the previous v3.6.5. This change reflects an updated revision of the study record.SummaryDifference0.1%

- Check55 days agoChange DetectedA new revision entry v3.6.5 was added to the record history and the previous revision v3.6.4 was removed, reflecting an update to the page's version history.SummaryDifference0.1%

- Check70 days agoChange DetectedA new site revision entry labeled v3.6.4 was added to the page history, and the previous revision v3.6.3 was removed. This reflects an update to the page’s underlying platform version rather than changes to the study information.SummaryDifference0.1%

- Check91 days agoChange DetectedThe record history now includes a new revision entry 'Revision: v3.6.3'. The previous entry 'Revision: v3.6.2' is no longer listed.SummaryDifference0.1%

- Check99 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and the older revision entry (v3.6.0) was removed, reflecting an update to the page's version history.SummaryDifference0.1%

Stay in the know with updates to Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pembrolizumab vs Topotecan in Small Cell Lung Cancer Clinical Trial page.